Pharvaris To Participate in the Morgan Stanley 21st Annual Global Healthcare Conference : vimarsana.com

ZUG, Switzerland, Sept. 06, 2023 -- Pharvaris , a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema attacks, will attend...

Related Keywords

New York , United States , Switzerland , Morgan Conn , Morgan Stanley , Annual Global Healthcare Conference , Chief Business Officer , Markets ,